Upper Airway Stimulation for Treatment of Obstructive Sleep Apnea
North Memorial has been established as a Center of Excellence for providing Inspire Upper Airway Stimulation (UAS), a new treatment for moderate to severe obstructive sleep apnea (OSA) approved by the FDA for use in patients who are unable to tolerate positive airway pressure (PAP) therapy.
OSA is a common condition estimated to affect more than 18 million Americans. It is caused by repetitive collapse or narrowing of the throat during sleep. Patients suffer from poor sleep quality with resulting daytime sleepiness impacting mood, job performance, driving safety, and cognitive function. Research has shown that OSA also promotes high blood pressure, diabetes, stroke, heart attack, heart failure, and abnormal heart rhythms.
The first-line treatment for OSA is often Continuous Positive Airway Pressure (CPAP), a small machine that keeps the upper airway open by gently providing a stream of air under pressure into a mask worn during sleep. Unfortunately, a number of patients are unable to tolerate this therapy or find it to be ineffective. Inspire offers new hope for treatment in this group of patients.
How Does Inspire UAS Work?
This device is implanted in the chest near the clavicle and turned on by the patient using a remote control before they go to sleep. It consists of a generator connected to two wires – one that senses the patient’s breathing pattern and another that stimulates the nerve that controls the tongue. The generator provides an electric pulse designed to move the base of the tongue out of the airway whenever the patient takes a breath during sleep, thereby keeping the upper airway open and preventing OSA.
Please refer to the video below and visit inspirebettersleep.com for more information.
The first step in assessing sleep quality and treating sleep apnea is an office consult. Sleep studies and provider consults are offered at: